Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Chloroacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroacetic Acid SCHEMBL28331788 | 0.96 | TSHR (0.71) | — | |
| Chloroacetic Acid SCHEMBL28645916 | 0.96 | TSHR (0.71) | — | |
| Chloroacetic Acid SCHEMBL29053349 | 0.96 | TSHR (0.71) | — | |
| Chloroacetic Acid SCHEMBL28118454 | 0.92 | — | — | |
| Chloroacetic Acid SCHEMBL9856939 | 0.88 | — | — | |
| Chloroacetic Acid SCHEMBL19089 | 0.88 | — | — | |
| Chloroacetic Acid SCHEMBL1330914 | 0.88 | — | — | |
| Chloroacetic Acid SCHEMBL1330649 | 0.88 | — | — | |
| Chloroacetic Acid SCHEMBL5309413 | 0.88 | TSHR (1.00) | — | |
| Chloroacetic Acid SCHEMBL1331987 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116115581-A | Ketorolac tromethamine biphasic controlled release tablet and preparation method thereof | 中国人民解放军中部战区总医院 | 2023-05-16 | — | — | CN | claimed |
| US-20220000788-A1 | METHOD FOR DRY POWDER COATING CAPSULES | NINGBO WESTON POWDER PHARMA COATINGS CO., LTD. (CN) | 2022-01-06 | — | — | US | claimed |
| US-20200222330-A1 | METHOD FOR DRY POWDER COATING CAPSULES | POWDER PHARMA COATING INC. (CA) | 2020-07-16 | — | — | US | claimed |
| US-20190099377-A1 | METHOD FOR DRY POWDER COATING OSMOTIC DRUG DELIVERY SYSTEM | NINGBO WESTON POWDER PHARMA COATINGS CO., LTD. (CN) | 2019-04-04 | — | — | US | claimed |
| US-20190099378-A1 | METHOD FOR DRY POWDER COATING CAPSULES | NINGBO WESTON POWDER PHARMA COATINGS CO., LTD. (CN) | 2019-04-04 | — | — | US | claimed |
| EP-2305624-B1 | Self-degradable explosive device | MAXAMCORP HOLDING SL (ES) | 2017-09-27 | — | — | EP | claimed |
| CN-206511431-U | A kind of production of chloroacetic acid acetic acid tank | 河北华栋化工有限责任公司 | 2017-09-22 | — | — | CN | claimed |
| EP-3108527-A1 | CROSS-LINKED BINDER FOR LITHIUM ION BATTERIES | Hercules LLC (US) | 2016-12-28 | — | — | EP | claimed |
| EP-3108526-A1 | MODIFIED GUARAN BINDER FOR LITHIUM ION BATTERIES | Hercules LLC (US) | 2016-12-28 | — | — | EP | claimed |
| US-20150243995-A1 | CROSS-LINKED BINDER COMPOSITION FOR LITHIUM ION BATTERIES AND METHODS FOR PRODUCING THE SAME | PHARMACHEM LABORATORIES LLC | 2015-08-27 | — | — | US | claimed |
| US-20040137156-A1 | Coated solid dosage form and method for preparing same | LEE ERNEST J | 2004-07-15 | — | — | US | claimed |
| WO-2004050066-A1 | MICROSPHERES AND RELATED PROCESSES AND PHARMACEUTICAL COMPOSITIONS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2004-06-17 | — | — | WO | claimed |
| US-6706283-B1 | INCREASING BIOAVAILABILITY OF SPARINGLY WATER SOLUBLE ACTIVE INGREDIENTS; CONTROLLED INFLUX OF WATER TO CORE USING NON-DISSOLVING, NONERODING COATING | PFIZER INC | 2004-03-16 | — | — | US | claimed |
| WO-2003092660-A1 | MONOCOMPARTMENT OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM | RANBAXY LABORATORIES LIMITED (US) | 2003-11-13 | — | — | WO | claimed |
| EP-1027888-A2 | Osmotic system for delivery of solid amorphous dispersions of drugs | Pfizer Products Inc. (US) | 2000-08-16 | — | — | EP | claimed |
| US-5612059-A | CELLULOSE DERIVATIVE, DRUG DELIVERY | PFIZER INC. (US) | 1997-03-18 | — | — | US | claimed |
| US-5458887-A | OF AN OSMOTIC CORE CONTAINING A DRUG AND A WATER SWELLABLE COMPONENT AND A WATER RESISTANT POLYMER COATING CONTAINING A COMPOUND WHICH DISSOLVES IN GASTROINTESTINAL FLUID | ANDRX PHARMACEUTICALS, INC. (US) | 1995-10-17 | — | — | US | claimed |
| EP-0326727-A1 | Sustained release implant and method for preparing same | INTERNATIONAL MINERALS AND CHEMICAL CORPORATION (US) | 1989-08-09 | — | — | EP | claimed |
| US-4761289-A | Sustained release implant and method for preparing same | INTERNATIONAL MINERALS & CHEMICAL CORP. (US) | 1988-08-02 | — | — | US | claimed |
| US-4035457-A | Nonbiodegradable polymers | CHEMICAL SYSTEMS INCORPORATED (US) | 1977-07-12 | — | — | US | claimed |